The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study

Fertility and Sterility

Volumn 88, Issue 1, 2007, Pages 107-112

  Cantineau, Astrid E P ^a,b   Cohlen, Bernard J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Intrauterine insemination; ovarian stimulation; premature LH surges; prospective; subfertility

Indexed keywords

CLOMIFENE CITRATE; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER SYSTEM; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HUMAN; INTRAUTERINE INSEMINATION; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; SINGLE BLIND PROCEDURE; SUBFERTILITY; TERTIARY HEALTH CARE; TREATMENT RESPONSE; TREND STUDY;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INSEMINATION, ARTIFICIAL; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RANDOM ALLOCATION;

EID: 34347215891     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.136     Document Type: Article

References (24)

1. Balasch J., Ballesca J.L., Pimentel C., Creus M., Fabregues F., and Vanrell J.A. Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles. Hum Reprod 9 (1994) 1863-1866
2. Cantineau A.E.P., Heineman M.J., and Cohlen B.J. Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review. Hum Reprod 18 (2003) 941-946
3. Costello M.F. Systematic review of treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination. Aust N Z J Obstet Gynaecol 44 (2004) 93-102
4. Cunha-Filho J.S., Kadoch J., Righini C., Fanchin R., Frydman R., and Olivennes F. Premature LH and progesterone rise in intrauterine insemination cycles: analysis of related factors. Reprod Biomed Online 7 (2003) 194-199
5. Urbancsek J., Rabe T., Grunwald K., and Runnebaum B. Diagnosis, incidence and clinical significance of premature LH rise/peak in patients of an in vitro fertilization and gamete transfer program. Geburtshilfe Frauenheilkd 50 (1990) 454-462
6. Cohlen B.J., te Velde E.R., van Kooij R.J., Looman C.W.N., and Habbema J.D.F. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Hum Reprod 12 (1998) 1553-1558
7. Goméz-Palomares J.L., Julia B., Acevedo-Martín B., Martínez-Burgos M., Hernández E.R., and Richiarelli E. Timing of ovulation for intrauterine insemination with a GnRH antagonist. Hum Reprod 20 (2005) 268-272
8. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd ed. (1992), Cambridge University Press, Cambridge
9. Cohlen B.J. Should we continue performing intrauterine inseminations in the year 2004?. Gynecol Obstet Invest 59 (2005) 3-13
10. Yavas Y., and Selub M.R. Intrauterine insemination (IUI) pregnancy outcome is enhanced by shorter intervals from semen collection to sperm wash, from sperm wash to IUI time, and from semen collection to IUI time. Fertil Steril 82 (2004) 1638-1647
11. Hughes E.G. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 12 (1997) 1865-1872
12. Guzick D.S., Carson S.A., Coutifaris C., Overstreet J.W., Factor-Ltivak P., Steinkampf M.P., et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 340 (1999) 177-183
13. Goverde A.J., McDonnell J., Vermeiden J.P.W., Schats R., Rutten F.F.H., and Schoenmaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 355 (2000) 13-18
14. Fauser B.C., Devroey P., and Macklon N.S. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365 (2005) 1807-1816
15. Martinez A.R., Bernardus R.E., Kucharska D., and Schoemaker J. Urinary luteinizing hormone testing and prediction of ovulation in spontaneous, clomiphene citrate and human menopausal gonadotropin-stimulated cycles. A clinical evaluation. Acta Endocrinol (Copenh) 124 (1991) 357-363
16. Mitwally M.F., Abdel-Razeq S., and Casper R.F. Human chorionic gonadotropins administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination. Reprod Biol Endocrinol 2 (2004) 55
17. Zreik T.G., García-Velasco J.A., Habboosh M.S., Olive D.L., and Arici A. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropins-timed vs. urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles. Fertil Steril 71 (1998) 1070-1074
18. Loydd R., and Coulman C.B. The accuracy of urinary luteinizing hormone testing in predicting ovulation. Am J Obstet Gynecol 160 (1989) 1370-1372
19. Albano C., Smitz J., Camus M., Riethmuller-Winzen H., Van Steirteghem A., and Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67 (1997) 917-922
20. Olivennes F., Alvarez S., Bouchard P., Fanchin R., Salat-Baroux J., and Frydman R. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod 13 (1998) 2411-2414
21. Borm G., Mannaerts B., and The European Orgalutran Study Group. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled randomized, multicentre trial. Hum Reprod 15 (2000) 1490-1498
22. Lambalk C.B., Leader A., Olivennes F., Fluker M.R., Andersen A.N., Ingerslev J., et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinisation in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 21 (2006) 632-639
23. Ragni G., Vegetti W., Baroni E., Colombo M., Arnoldi M., Lombroso G., and Crosignani P.G. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod 16 (2001) 2258-2262
24. Williams R.S., Hillard J.B., De Vane G., Yeko T., Kipersztok S., Rhoton-Vlasak A., and Sistrom C. A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with ganirelix during superovulation/IUI therapy. Am J Obstet Gynecol 191 (2004) 648-651